12 novel scopoletin-isoxazole and scopoletin-pyrazole hybrids have been designed and synthesized. Their anti-tumor activities against HCT-116, Huh7 and SW 620 cells in vitro were evaluated. Compound 9d displayed significant anti-proliferative activity on tumor cells and weak cytotoxicity on normal cells.